Rhumbline Advisers Liva Nova PLC Transaction History

Rhumbline Advisers

  • $109 Billion
  • Q3 2024

A detailed history of Rhumbline Advisers transactions in Liva Nova PLC stock. As of the latest transaction made, Rhumbline Advisers holds 177,039 shares of LIVN stock, worth $9.09 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
177,039
Previous 183,132 3.33%
Holding current value
$9.09 Million
Previous $10 Million 7.4%
% of portfolio
0.01%
Previous 0.01%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024
SELL
$43.38 - $54.59 $264,314 - $332,616
-6,093 Reduced 3.33%
177,039 $9.3 Million
Q2 2024

Aug 01, 2024
BUY
$51.76 - $64.15 $34,109 - $42,274
659 Added 0.36%
183,132 $10 Million
Q1 2024

May 09, 2024
BUY
$48.6 - $57.12 $131,560 - $154,623
2,707 Added 1.51%
182,473 $10.2 Million
Q4 2023

Feb 08, 2024
SELL
$43.45 - $53.66 $322,485 - $398,264
-7,422 Reduced 3.96%
179,766 $9.3 Million
Q3 2023

Nov 09, 2023
BUY
$50.12 - $58.87 $56,886 - $66,817
1,135 Added 0.61%
187,188 $9.9 Million
Q2 2023

Aug 08, 2023
BUY
$42.28 - $51.43 $413,625 - $503,139
9,783 Added 5.55%
186,053 $9.57 Million
Q1 2023

May 11, 2023
BUY
$40.84 - $58.14 $29,404 - $41,860
720 Added 0.41%
176,270 $7.68 Million
Q4 2022

Feb 14, 2023
BUY
$43.88 - $56.16 $354,023 - $453,098
8,068 Added 4.82%
175,550 $9.75 Million
Q3 2022

Nov 10, 2022
BUY
$48.37 - $66.5 $275,805 - $379,183
5,702 Added 3.52%
167,482 $8.5 Million
Q2 2022

Aug 11, 2022
BUY
$57.25 - $86.63 $810,602 - $1.23 Million
14,159 Added 9.59%
161,780 $10.1 Million
Q1 2022

May 12, 2022
BUY
$71.02 - $86.99 $211,639 - $259,230
2,980 Added 2.06%
147,621 $12.1 Million
Q4 2021

Feb 10, 2022
SELL
$76.72 - $92.68 $87,690 - $105,933
-1,143 Reduced 0.78%
144,641 $12.6 Million
Q3 2021

Nov 12, 2021
BUY
$76.02 - $88.62 $790,455 - $921,470
10,398 Added 7.68%
145,784 $11.5 Million
Q2 2021

Aug 05, 2021
SELL
$73.44 - $87.01 $343,038 - $406,423
-4,671 Reduced 3.34%
135,386 $11.4 Million
Q1 2021

May 06, 2021
SELL
$62.9 - $82.41 $331,294 - $434,053
-5,267 Reduced 3.62%
140,057 $10.3 Million
Q4 2020

Feb 10, 2021
BUY
$46.01 - $68.74 $217,443 - $324,865
4,726 Added 3.36%
145,324 $9.62 Million
Q3 2020

Nov 12, 2020
SELL
$41.91 - $57.81 $685,815 - $946,002
-16,364 Reduced 10.43%
140,598 $6.36 Million
Q2 2020

Aug 13, 2020
BUY
$39.87 - $56.9 $299,662 - $427,660
7,516 Added 5.03%
156,962 $7.56 Million
Q1 2020

May 06, 2020
BUY
$34.22 - $76.49 $61,424 - $137,299
1,795 Added 1.22%
149,446 $6.76 Million
Q4 2019

Feb 05, 2020
SELL
$68.92 - $85.27 $190,494 - $235,686
-2,764 Reduced 1.84%
147,651 $11.1 Million
Q3 2019

Oct 23, 2019
SELL
$71.74 - $86.35 $47,276 - $56,904
-659 Reduced 0.44%
150,415 $11.1 Million
Q2 2019

Aug 14, 2019
BUY
$66.45 - $97.36 $106,452 - $155,970
1,602 Added 1.07%
151,074 $10.9 Million
Q1 2019

May 01, 2019
BUY
$86.15 - $100.49 $119,748 - $139,681
1,390 Added 0.94%
149,472 $14.5 Million
Q4 2018

Jan 31, 2019
BUY
$84.14 - $125.42 $4.92 Million - $7.33 Million
58,422 Added 65.16%
148,082 $13.5 Million
Q3 2018

Nov 07, 2018
BUY
$101.02 - $130.95 $33,942 - $43,999
336 Added 0.38%
89,660 $11.1 Million
Q2 2018

Aug 06, 2018
SELL
$81.75 - $105.37 $195,954 - $252,571
-2,397 Reduced 2.61%
89,324 $8.92 Million
Q1 2018

May 02, 2018
SELL
$79.95 - $89.74 $525,911 - $590,309
-6,578 Reduced 6.69%
91,721 $8.12 Million
Q4 2017

Feb 09, 2018
BUY
$71.8 - $88.21 $257,403 - $316,232
3,585 Added 3.79%
98,299 $7.86 Million
Q3 2017

Nov 06, 2017
BUY
$60.32 - $70.06 $5.71 Million - $6.64 Million
94,714
94,714 $6.64 Million

Others Institutions Holding LIVN

# of Institutions
261
Shares Held
53M
Call Options Held
316K
Put Options Held
127K
View Full List

About LivaNova PLC

LIVN Quotes by TradingView
  • Ticker LIVN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 53,545,700
  • Market Cap $2.75B
  • Description
  • LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. It operates through three segments: Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines,...
More about LIVN
Track This Portfolio

Track Rhumbline Advisers Portfolio

Follow Rhumbline Advisers and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Rhumbline Advisers with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email